Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 -1.42%94 Days Payable is 81.23 as of Jun. 2026, which is 34% below its 10-year median of 123.46. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,557.68 (Fairly Valued). The stock has 3 warning signs investors should review. Among 609 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks better than 70.44% on this metric.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's Days Payable or its related term are showing as below:
BOM:526783'
s Days Payable Range Over the Past 10 Years
Min: 83.98 Med: 123.46 Max: 175.92
Current: 98.53
During the past 13 years, Dr Agarwal'S Eye Hospital's highest Days Payable was 175.92. The lowest was 83.98. And the median was 123.46.
BOM:526783's Days Payable is ranked better than 70.44% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 57.48
vs BOM:526783: 98.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:526783 vs HCA, THC, EHC: Days Payable Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's Days Payable distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's Days Payable falls into.
Dr Agarwal'S Eye Hospital Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Dr Agarwal'S Eye Hospital's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital (BOM:526783) has a Days Payable of 81.23 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 34% below median its historical median of 123.46. Over the past decade, Dr Agarwal'S Eye Hospital's Days Payable has ranged from 83.98 to 175.92. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #180 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 29.6%.
Is Dr Agarwal'S Eye Hospital's Days Payable too high?
Dr Agarwal'S Eye Hospital's current Days Payable of 81.23 is 34% below median its 10-year median of 123.46. Over the past 10 years, this metric has ranged from a low of 83.98 to a high of 175.92. The Healthcare Providers & Services industry median Days Payable is 57.48. Dr Agarwal'S Eye Hospital's value of 81.23 is 41.3% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #180 out of 609 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #180 out of 609 companies for Days Payable. This puts Dr Agarwal'S Eye Hospital in the upper half of its industry. The industry median Days Payable is 57.48. Dr Agarwal'S Eye Hospital's value of 81.23 is 41.3% above this benchmark. Historically, Dr Agarwal'S Eye Hospital's own Days Payable has ranged from 83.98 to 175.92 over the past decade. While the company's 10-year median is 123.46 vs. the industry median of 57.48, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.48, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current Days Payable of 81.23 is 41.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current Days Payable is 81.23, which is 34% below median its own 10-year median of 123.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,557.68, compared to a current price of ₹5,315.90 — trading 4.4% below its estimated fair value. The current Days Payable is 81.23, which is 34% below median its 10-year median of 123.46 and 41.3% above the Healthcare Providers & Services industry median of 57.48. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current Days Payable is 81.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,315.90 is trading 4.4% below its estimated GF Value™ of ₹5,557.68.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
Days Payable: 81.23 (34% below median its 10-year median of 123.46)
GF Value™: ₹5,557.68 vs. price of ₹5,315.90 (4.4% below fair value)
Industry Position: 41.3% above the Healthcare Providers & Services median (#180 of 609)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score
Get the complete analysis for BOM:526783
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
